Due to the large number of novel AD biomarkers that have been reported and reviewed in the literature [32,37,38], in the next sections we will focus on optical detection methods reported using metal nanoparticles for sensing Aβ, tau, and other biomarkers in clinically relevant fluids. This evidence concerns the gene MAPT and Alzheimer disease.